Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
s save search
Zealand Pharma Partners with Benchling to Advance R&D of Engineered Peptide Medicines
Published: 2024-04-23 (Crawled : 08:00) - prnewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
SNIPR Biome receives funding from CARB-X to support advancement of CRISPR-medicine SNIPR001 into clinical trials in haematological cancer patients
Published: 2024-04-22 (Crawled : 18:00) - biospace.com/
NVO | News | $125.26 2.08% 1.22% 22K
|
Health Technology
|
| O: -0.1%
H: 2.99%
C: 2.18%
snipr001 cancer trials funding
Eco Bright Future, Inc.'s Subsidiary United Heritage Group to Lead Tokenization Efforts in El Salvador
Published: 2024-04-22 (Crawled : 13:00) - globenewswire.com
EBFI | News | $3.05 -6.15% 0
|
|
| O: 0.31%
H: 0.0%
C: -6.44%
group
Novo Nordisk A/S - share repurchase programme
Published: 2024-04-22 (Crawled : 13:00) - globenewswire.com
NVO | News | $125.26 2.08% 1.22% 22K
|
Health Technology
|
| O: -0.1%
H: 2.99%
C: 2.18%
repurchase
trivago N.V.'s First Quarter 2024 Earnings Release Scheduled for April 30, 2024; Webcast Scheduled for May 1, 2024
Published: 2024-04-22 (Crawled : 12:00) - globenewswire.com
TRVG | News | $2.57 -1.98% 34
|
Technology Services
|
| O: 0.98%
H: 5.06%
C: 0.0%
first for
Investors in Evolv Technologies Holdings, Inc. Should Contact Levi & Korsinsky Before May 24, 2024 to Discuss Your Rights - EVLV
Published: 2024-04-22 (Crawled : 10:00) - prnewswire.com
EVLV | News | $3.915 0.9% 22K
|
|
| O: -1.78%
H: 0.0%
C: 0.0%
DKS | News | $200.85 1.1% 13K
|
Retail Trade
|
| O: 0.66%
H: 1.56%
C: 1.01%
INOD | News | $5.69 5.3K
|
Technology Services
|
| O: 0.26%
H: 1.37%
C: -2.57%
IESC | News | $117.68 4.3K
|
Industrial Services
|
| O: -0.01%
H: 0.0%
C: 0.0%
Transactions in Connection with Share Buy-back Program Genmab
Published: 2024-04-22 (Crawled : 08:00) - globenewswire.com
GNMSF | News | $289.67 5.3K
|
Health Technology
|
| O: -1.68%
H: 3.85%
C: 3.54%
GMAB | News | $28.97 9.3K
|
Health Technology
|
| O: 0.66%
H: 1.25%
C: 0.42%
program
IHT S-3 OPENS DOORS FOR DIVERSIFICATION CAPITAL INFUSION
Published: 2024-04-19 (Crawled : 21:00) - globenewswire.com
IHT P | $1.45 100
|
Finance
| Email alert
Add to watchlist
for
Correction to Company announcement – No. 23 / 2024
Published: 2024-04-19 (Crawled : 20:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
announcement company
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.42%
NVO | News | $125.26 2.08% 1.22% 22K
|
Health Technology
|
| O: -0.84%
H: 0.86%
C: -0.62%
GSK | News | $40.795 0.51% 150K
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
LLY | News | $735.9 0.63% 180K
|
Health Technology
|
| O: -0.21%
H: 0.11%
C: -3.05%
AZN | News | $70.48 0.5% 500K
|
Health Technology
|
| O: -0.18%
H: 0.84%
C: 0.6%
report reach therapeutics market
Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma management for
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma
Shareholders that lost money on Innodata Inc.(INOD) should contact The Gross Law Firm about pending Class Action - INOD
Published: 2024-04-19 (Crawled : 10:00) - prnewswire.com
INOD | News | $5.69 5.3K
|
Technology Services
|
| O: -1.19%
H: 0.0%
C: 0.0%
FOXF | $40.79 0.32% 4.4K
|
Consumer Durables
|
| O: -1.7%
H: 1.41%
C: 0.02%
PLCE | $7.54 -8.61% -9.56% 4.1K
|
Retail Trade
|
| O: -6.49%
H: 9.91%
C: 2.23%
Shareholders that lost money on SSR Mining Inc.(SSRM) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
Published: 2024-04-19 (Crawled : 10:00) - prnewswire.com
DKS | News | $200.85 1.1% 13K
|
Retail Trade
|
| O: -0.7%
H: 0.0%
C: 0.0%
SSRM | $5.21 -2.43% -2.69% 3.4K
|
Non-Energy Minerals
|
| O: -0.58%
H: 0.0%
C: 0.0%
AVXL | $3.7 0.54% 17K
|
Health Technology
|
| O: -7.62%
H: 1.06%
C: 0.53%
mining
Investors who lost money on The Chemours Company(CC) should contact The Gross Law Firm about pending Class Action - CC
Published: 2024-04-19 (Crawled : 10:00) - prnewswire.com
CC | $26.8 1.4% 25K
|
Process Industries
|
| O: -0.54%
H: 0.0%
C: 0.0%
FOXF | $40.79 0.32% 4.4K
|
Consumer Durables
|
| O: -1.7%
H: 1.41%
C: 0.02%
PLCE | $7.54 -8.61% -9.56% 4.1K
|
Retail Trade
|
| O: -6.49%
H: 9.91%
C: 2.23%
Printing & Promotions Plus, Inc.’s Strengthens Capabilities With Inclusion of Colorado M series and Arizona 135 GT Printers from Canon Solutions America
Published: 2024-04-18 (Crawled : 15:00) - globenewswire.com
CAJ | News | $21.63 -0.37% 0
|
Electronic Technology
| Email alert
Add to watchlist
CAJPY | $28.81 91K
|
n/a
| Email alert
Add to watchlist
CAJFF | $29.0664 -28.15% 760
|
Electronic Technology
| Email alert
Add to watchlist
america series solutions
Diana Shipping Inc. Announces Time Charter Contract for m/v P. S. Palios
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
DSX | $2.88 56K
|
Transportation
|
| O: 0.17%
H: 0.0%
C: 0.0%
contract for
Chuy’s Holdings, Inc. to Announce First Quarter 2024 Results on May 9, 2024
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
CHUY | $30.38 -0.69% -0.66% 0
|
Consumer Services
|
| O: -1.65%
H: 0.0%
C: 0.0%
results
Denny's Unveils New Spring Menu Featuring the Berry Waffle Slam®, BBQ Bacon Chicken Sandwich, and Brownie Sundae with Oreo® Pieces!
Published: 2024-04-17 (Crawled : 14:00) - globenewswire.com
DENN | $8.2 0.37% 0.37% 0
|
Consumer Services
|
| O: 0.97%
H: 0.0%
C: 0.0%
slam spring
Ventus Therapeutics Announces Results from Phase 1 Clinical Trial of VENT-02, a Novel, Orally Administered, Brain-Penetrant NLRP3 Inhibitor
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
NVO | News | $125.26 2.08% 1.22% 22K
|
Health Technology
|
| O: 1.22%
H: 0.21%
C: -0.34%
vent-02 trial therapeutics results
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.625 165.81% 5.5M
|
AGBA | $2.615 109.2% 14M
|
Finance
EDBL | News | $7.37 96.01% 650K
|
MLEC | $1.87 33.57% 1.6M
|
n/a
ATGL | $3.66 27.97% 150K
|
KULR | $0.5446 22.0% 6.8M
|
Manufacturing
MDIA 4 | $2.205 21.15% 150K
|
Consumer Services
LYT | $4.96 20.68% 610K
|
HIBB 4 | $85.785 18.34% 1M
|
Retail Trade
AZTR 4 | $0.222 13.85% 220K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.